Literature DB >> 33445645

Quantitative Evaluation of Fibrosis in IPF Patients: Meaning of Diffuse Pulmonary Ossification.

Monica Palermo1, Francesco Tiralongo1, Giulio Distefano1, Ada Vancheri2, Mauro Giuffrè3, Fabio Pino2, Pietro Valerio Foti1, Gianluca Sambataro2, Carlo Vancheri2, Stefano Palmucci1, Antonio Basile1.   

Abstract

To investigate the role of diffuse pulmonary ossification (DPO) in disease severity in a population of Idiopathic Pulmonary Fibrosis (IPF) patients. This retrospective study was carried out on 95 IPF patients-44 with DPO on high resolution computed tomography (HRCT) and 51 with no calcifications detected on HRCT. Pulmonary Function Tests (PFTs) acquired nearest to the HRCT were collected. Images were analyzed by two radiologists using a qualitative method, based on HRCT fibrosis visual score, and using a quantitative method, based on histogram-based analysis. The Spearman's rank correlation coefficient was used to measure the strength and direction of the linear relationship between HRCT fibrosis score and PFTs; in addition, Spearman's rank correlation coefficient was used to explore the relationships between HRCT fibrosis score and quantitative index and between quantitative indexes and PFTs. A weak correlation between HRCT fibrosis score and PFTs was proven (r =-0.014 and p = 0.9347 for FVC (Forced Vital Capacity), r = -0.379 and p = 0.0174 for DLCO (Carbon monoxide diffusing capacity)). We found a moderate negative correlation between HRCT fibrosis score and kurtosis (r = -0.448, p = 0.004272) and skewness (r = -0.463, p = 0.003019) and a weak positive correlation with High Attenuation Area (HAA)% (r = 0.362, p = 0.0235). Moreover, a moderate linear correlation between Quantitative Indexes and FVC (r = 0.577, p = 0.000051 for kurtosis and FVC, r = 0.598, p = 0.000023 for skewness and FVC, r = -0.519, p = 0.0000364 for HAA% and FVC) and between quantitative indexes and DLCO (r = 0.469, p = 0.001508 for kurtosis, and DLCO, r = 0.474, p = 0.001309 for skewness and DLCO, r = -0.412, p = 0.005996 for HAA% and DLCO) was revealed. To better investigate the influence of DPO in disease progression, a longitudinal evaluation should be performed.

Entities:  

Keywords:  HRCT; IPF; fibrosis; histogram-based analysis; interstitial lung diseases; kurtosis; lung diseases; pulmonary ossification; quantification; visual score

Year:  2021        PMID: 33445645      PMCID: PMC7828113          DOI: 10.3390/diagnostics11010113

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  28 in total

1.  Nodular pulmonary ossifications in differential diagnosis of solitary pulmonary nodules.

Authors:  J Gielis; M Torfs; M Luijks; R Salgado; P E Van Schil
Journal:  Eur Respir J       Date:  2011-04       Impact factor: 16.671

2.  Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis.

Authors:  Xiaoping Wu; Grace H Kim; Margaret L Salisbury; David Barber; Brian J Bartholmai; Kevin K Brown; Craig S Conoscenti; Jan De Backer; Kevin R Flaherty; James F Gruden; Eric A Hoffman; Stephen M Humphries; Joseph Jacob; Toby M Maher; Ganesh Raghu; Luca Richeldi; Brian D Ross; Rozsa Schlenker-Herceg; Nicola Sverzellati; Athol U Wells; Fernando J Martinez; David A Lynch; Jonathan Goldin; Simon L F Walsh
Journal:  Am J Respir Crit Care Med       Date:  2019-01-01       Impact factor: 21.405

3.  Diffuse Pulmonary Ossification in Fibrosing Interstitial Lung Diseases: Prevalence and Associations.

Authors:  Ryoko Egashira; Joseph Jacob; Maria A Kokosi; Anne-Laure Brun; Alexandra Rice; Andrew G Nicholson; Athol U Wells; David M Hansell
Journal:  Radiology       Date:  2017-02-09       Impact factor: 11.105

Review 4.  Pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Paul J Wolters; Harold R Collard; Kirk D Jones
Journal:  Annu Rev Pathol       Date:  2013-09-13       Impact factor: 23.472

Review 5.  Evaluating disease severity in idiopathic pulmonary fibrosis.

Authors:  Hasti Robbie; Cécile Daccord; Felix Chua; Anand Devaraj
Journal:  Eur Respir Rev       Date:  2017-09-06

6.  Disseminated dendriform pulmonary ossification associated with usual interstitial pneumonia: incidence and thin-section CT-pathologic correlation.

Authors:  Tae Sung Kim; Joungho Han; Man Pyo Chung; Myung Jin Chung; Yong Soo Choi
Journal:  Eur Radiol       Date:  2005-04-23       Impact factor: 5.315

7.  Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis.

Authors:  Mauro Giuffrè; Daniele Macor; Flora Masutti; Cristiana Abazia; Fabio Tinè; Giorgio Bedogni; Claudio Tiribelli; Lory Saveria Crocè
Journal:  Ann Hepatol       Date:  2019-10-23       Impact factor: 2.400

Review 8.  Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype.

Authors:  Yoshikazu Inoue; Robert J Kaner; Julien Guiot; Toby M Maher; Sara Tomassetti; Sergey Moiseev; Masataka Kuwana; Kevin K Brown
Journal:  Chest       Date:  2020-04-05       Impact factor: 9.410

9.  Densitometric and local histogram based analysis of computed tomography images in patients with idiopathic pulmonary fibrosis.

Authors:  Samuel Y Ash; Rola Harmouche; Diego Lassala Lopez Vallejo; Julian A Villalba; Kris Ostridge; River Gunville; Carolyn E Come; Jorge Onieva Onieva; James C Ross; Gary M Hunninghake; Souheil Y El-Chemaly; Tracy J Doyle; Pietro Nardelli; Gonzalo V Sanchez-Ferrero; Hilary J Goldberg; Ivan O Rosas; Raul San Jose Estepar; George R Washko
Journal:  Respir Res       Date:  2017-03-07

10.  Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Jeffrey L Myers; Luca Richeldi; Christopher J Ryerson; David J Lederer; Juergen Behr; Vincent Cottin; Sonye K Danoff; Ferran Morell; Kevin R Flaherty; Athol Wells; Fernando J Martinez; Arata Azuma; Thomas J Bice; Demosthenes Bouros; Kevin K Brown; Harold R Collard; Abhijit Duggal; Liam Galvin; Yoshikazu Inoue; R Gisli Jenkins; Takeshi Johkoh; Ella A Kazerooni; Masanori Kitaichi; Shandra L Knight; George Mansour; Andrew G Nicholson; Sudhakar N J Pipavath; Ivette Buendía-Roldán; Moisés Selman; William D Travis; Simon Walsh; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2018-09-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.